3.4.23.34	medicine	antitumor activity of cathepsin E in human prostate carcinoma tumor cell lines	679028	
3.4.23.34	medicine	cathepsin E is a specific marker of dysplasia in APC(Min/+) mouse intestine. Potential utility for catE as a marker for the inception and progression of intestinal cancers	670982	
3.4.23.34	medicine	combination of cathepsin E and doxorubicin is sufficient to overcome resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in chemoresistant prostate cancer PPC-1 cells	707628	
3.4.23.34	medicine	pancreas-bearing pancreatic intraepithelial neoplasia lesions and pancreatic tumours show an elevated expression of cathepsin E, allowing selective in-vivo detection of human pancreatic ductal adenocarcinoma xenografts and imaging of pancreas with pancreatic intraepithelial neoplasia lesions and pancreatic tumours in genetically engineered mouse models of pancreatic cancer	717647	
3.4.23.34	molecular biology	CatE is a potential cancer biomarker	679028	
3.4.23.34	additional information	CatE is essential for processing of ovalbumin by murine B-cells, Cat E could play a major role in antigen processing, involvement of CatE in the MHC class II pathway	677990